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Abstract
Certain parasites have evolved to evade the immune response and establish chronic infections that may persist for many
years. T cell responses in these conditions become muted despite ongoing infection. Upregulation of surface receptors with
inhibitory properties provides an immune cell-intrinsic mechanism that, under conditions of chronic infection, regulates
immune responses and limits cellular activation and associated pathology. The negative regulator, CD200 receptor, and its
ligand, CD200, have been shown to regulate macrophage activation and reduce pathology following infection. We show
that CD4 T cells also increase expression of inhibitory CD200 receptors (CD200R) in response to chronic infection. CD200R
was upregulated on murine effector T cells in response to infection with bacterial, Salmonella enterica, or helminth,
Schistosoma mansoni, pathogens that respectively drive predominant Th1- or Th2-responses. In vitro chronic and prolonged
stimuli were required for the sustained upregulation of CD200R, and its expression coincided with loss of multifunctional
potential in T effector cells during infection. Importantly, we show an association between IL-4 production and CD200R
expression on T effector cells from humans infected with Schistosoma haematobium that correlated effectively with egg
burden and, thus infection intensity. Our results indicate a role of CD200R:CD200 in T cell responses to helminths which has
diagnostic and prognostic relevance as a marker of infection for chronic schistosomiasis in mouse and man.
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Introduction
Among parasitic diseases, schistosomiasis is a major cause of
morbidity in the developing world with high prevalence and
serious disease-associated disability and socio-economic impact
[1,2]. In endemic areas the burden of helminth infection is
frequently mixed [3], with a small proportion of individuals
suffering much higher infection loads than others. Children
generally lack adaptive immunity to schistosomes and are more
likely to accumulate substantial worm burden resulting in
diminished physical fitness and impaired development [4]. How
effective anti-helminth immunity is developed and maintained is
still unknown and early prognostic tools to distinguish individuals
more likely to progress into severe disease are needed.
Recently, it has become clear that helminths modulate the
balance between effector and immunoregulatory mechanisms
during infection [5]. Furthermore re-exposure to helminth-derived
antigens (Ag) induces T cell anergy [6], potentially undermining
pathogen elimination, yet it remains undetermined whether
anergy is a risk factor for disease severity in schistosomiasis.
Indeed, immune responses must be initiated and terminated
appropriately to maintain peripheral tolerance and immune
homeostasis. In this context, T cell suppression/anergy might be
beneficial to limit immune-mediated damage and fibrosis in self-
tissues in severe schistosomiasis.
Potentially self-damaging peripheral T cell responses are
regulated by cell extrinsic mechanisms, such as the induction of
T regulatory cells and intrinsically via the upregulation of surface
inhibitory receptors. The latter include the CD28-superfamily
members CTLA-4, ICOS and PD-1 [7], which are expressed on
activated T cells during immune responses. Interaction of these
receptors with their ligands: CD80/CD86, B7H2 and PD-L1/PD-
L2, regulates T cell activity [8,9,10,11]. Another inhibitory
receptor:ligand pair, CD200 receptor (CD200R):CD200 (OX-2),
has so far been studied mainly in myeloid cells [12].
CD200R:CD200 interaction delivers inhibitory signals, downreg-
ulating the activity of CD200R bearing cells [13]. CD200R
expression has been reported primarily in myeloid lineage subsets
such as: macrophages, dendritic cells (DC), mast cells, neutrophils
and basophils [14,15], while CD200 is more widely expressed on
T and B cells, DC, endothelium and neurons [16,17]. CD200
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Figure 1. T cells co-express CD200 and CD200R following TCR activation. A. Naı¨ve C57BL/6 peripheral LN cells were cultured with a titration
of anti-CD3 + anti-CD28 (2 mg/ml) for 3d. Contour plots show upregulation of CD200 (upper row) and CD200R (lower row) together with CD44 (R1) in
gated CD4 cells. B. DO11.10 LN and spleen cells were cultured with a titration of OVA peptide (ISQAVHAAHAEINEAGR) for 3d. CD200R:CD200 co-
expression (R1) is shown in gated CD4 cells. C. Naı¨ve LN cells were stimulated with anti-CD3 (1 mg/ml) + anti-CD28 (2 mg/ml) either transiently on Ab-
coated wells for the first 2d then removed to fresh media (blue lines) or chronically with Ab-coated aAPC present throughout the culture (red lines) in
Th1 (top row), Th2 (middle row) or non-polarising (IL-7, bottom row) conditions. Histograms show expression of CD200 and CD200R in gated CD4
CD200R:CD200 Upregulation in CD4 T Cells
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deficient (CD200–/–) mice display increased susceptibility to T cell-
mediated autoimmune diseases [18] and have greater sensitivity to
influenza infection, largely due to a failure in regulation of airway
macrophages [19]. Enhanced pathological T cell responses were
also reported in influenza infected CD200–/– mice [20]. Thus,
CD200R:CD200 interactions are important in immune regulation
and pathology. However, to date any suggestion that
CD200R:CD200 influences T cell responses has largely come
from tumor studies [21,22] and it remains largely unknown how
CD200R and CD200 are regulated in T cells during infection.
Expression of CD200R [14,15] and CD200 [17,18] on
subpopulations of human and mouse peripheral T cells was
reported previously and CD200 expression increased in activated
T cells in vitro [19,23]. Similarly, high expression of CD200R was
detected in more differentiated, central and effector memory
T cells [14] and was particularly apparent in polarized Th2 cells
[15]. Thus, we sought to investigate the upregulation of CD200
and, particularly, CD200R on T cells during persistent Ag
exposure. We show that chronicity of Ag stimulation influenced
both CD200 and CD200R expression by mouse T cells under
either Th1 or Th2 culture conditions. Furthermore, during
sustained Ag-exposure in vivo, CD200R expression increased in
Th2 (Schistosoma mansoni) and Th1 (Salmonella enterica) infection
models. Finally, we found significant correlation between infection
intensity and CD200R expression by Th2 prone cells from
Schistosoma haematobium infected humans. Our results show that
chronic Ag exposure results in CD200/CD200R upregulation on
T cells irrespective of the cytokine milieu. Importantly, our data
indicate that CD200R expression by CD4 T cells is a useful
indicator of infection intensity and T cell function in areas of
endemic schistosomiasis. Thus analysis of CD200R expression on
T cells may facilitate early diagnosis, the evaluation of disease
progression and the impact of pharmacological interventions on
these neglected diseases.
Results
Sustained TCR-signals Drive Co-expression of CD200 and
CD200R in T Cells
Activated T cells upregulated CD200 in vitro [23] and memory
T cells expressed more CD200R ex vivo than their naive
counterparts [14], yet it was unclear whether T cells co-expressed
both CD200 and CD200R, and whether upregulation of these
molecules was influenced by the strength of TCR stimulation. We
characterised the expression of CD200 and CD200R on T cells
following TCR activation in vitro. Lymph node (LN) cells from
naı¨ve mice were stimulated with a titration of anti-CD3 mAb
together with anti-CD28 mAb for 3 days. CD4 T cells upregu-
lated CD44, a stable marker of activation, together with CD200
and CD200R in a dose dependent manner (Figure 1A, R1; Figure
S1A). Similarly DO11.10 TCR transgenic cells upregulated and
co-expressed CD200 and CD200R in response to increasing doses
of antigenic peptide (Figure 1B, R1). Neither CD200 nor CD200R
were upregulated on T cells cultured in IL-7 (Figure S1A), which
promotes naı¨ve cell survival without activation [24].
We asked whether expression of CD200R and CD200 was
affected by either the duration of TCR stimulation or additional
cytokine signals provided in Th1, Th2 and non-polarising (IL-7)
conditions. Naı¨ve CD4 T cells were transiently stimulated (48h)
with anti-CD3 and anti-CD28 mAb-coated wells before removal
to fresh medium for the remainder of the culture. Alternatively,
sustained, chronic TCR stimulation was provided by continuous
culture with artificial antigen presenting cells (aAPC) coated with
anti-CD3 and anti-CD28 mAb [25]. At d3 both of these stimuli
elicited comparable activation of the T cells as judged by CD25
and CD44 upregulation (Figure S1B). Under Th1 polarising
conditions, activated CD44hi CD25+ T cells were shown to
express CD200 and this expression was maintained until d7 in
both transiently and chronically stimulated cells. Transient
stimulation in Th2 or neutral conditions provoked less upregula-
tion of CD200 at d3, and by d7 levels had dropped close to
background. Sustained stimulation produced comparable and
durable expression of CD200 regardless of polarising environ-
ment.
In contrast, modest upregulation of CD200R was observed by
d3 in any culture conditions (Figure 1C). By d7 more extensive
upregulation of CD200R occurred, but only after chronic
stimulation (Figure 1C and S2A). In all cases T cells up-regulated
both CD200 and CD200R compared to naı¨ve CD4 T cells
(Figure 1C) and the two molecules were co-expressed by the
majority of the cells upon chronic stimulation (Figure S2A). In
addition both molecules were co-expressed on activated
CD44+CD25+ T cells (Figure S2B). Thus the key determining
factor influencing CD200R expression was the chronicity of the
TCR stimulation, whereas CD200 expression was influenced both
by sustained stimulation and the polarising environment.
Multifunctional Potential is Decreased in CD200R
Expressing CD4 T Cells
CD200R, but not CD200, delivers inhibitory signals at least in
myeloid lineage cells, therefore we investigated CD200R expres-
sion during T cell differentiation. Activated T cells initially secrete
multiple cytokines, for example, IL-2, TNFa and IFNc [26].
However, upon chronic Ag exposure, which induces terminal
differentiation of CD4 T cells into short-lived Th1 [26,27] or Th2
[28] effector cells, the multifunctional potential of T cells becomes
exhausted together with their proliferative potential.
CD4 T cells expressed low levels of CD200R during the first
three days of stimulation and mainly produced IL-2 and TNFa
irrespectively of the polarising conditions in the culture (data not
shown). By d7 transiently stimulated Th2 cells were still largely
CD200R negative and continued to produce multifunctional
cytokines, TNFa and IL-2, similar to naı¨ve T cells. In contrast,
chronically stimulated cells upregulated CD200R and lost the
ability to secrete TNFa and IL-2 (Figure 2A-B and Figure S3E-F).
Concomitant with the loss of multifunctional cytokine production,
in Th2 culture conditions, a substantial fraction of the chronically
stimulated cells produced IL-4, or IL-4 mRNA as measured by
eGFP expression in 4-get T cells (Figure 2A) [29]. Similarly under
Th1 polarised culture conditions (Figure 2B), the potential to
secrete TNFa and IL-2 was also decreased following chronic TCR
stimulation, which favoured the upregulation of CD200R
expression (Figure 2B and Figure S3C-D). These data support
the hypothesis that in vitro CD200R expression is acquired by cells
that have decreased multifunctional cytokine potential.
cells at d3 (left) and d7 (right) compared to naı¨ve levels (grey filled histograms). Data are representative of 6 independent experiments and statistical
validation is shown in Figure S1A and S3C.
doi:10.1371/journal.pone.0035466.g001
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Chronic Schistosomiasis Leads to CD200 and CD200R Co-
expression in T Cells
Sustained TCR stimulation induced CD200R:CD200 co-
expression in T cells in vitro (Figure 1) but it was unknown
whether this might similarly occur in vivo. We infected mice with
Schistosoma mansoni cercariae [30] which develop into adult worms
and by 6–8 weeks post-infection continuously produce eggs which
provide persistent systemic Schistosome Egg Ags and drive a
chronic Th2 response [5]. At week 8 post-infection, we analysed
CD200 and CD200R expression in T cells from the mesenteric
LN (MesLN) together with CD44 to distinguish Ag-primed
(CD44hi) from naı¨ve (CD44lo) cells [31].
In uninfected control mice the majority of CD4 T cells were of
naive CD44lo phenotype (R1, Figure 3A and 3B), with the
remainder showing a memory/effector (CD44hi) T cell pheno-
type, consistent with exposure to environmental Ags (Figure 3A,
R2+R3 and Figure S4A). CD200 was essentially absent from the
CD44lo population (Figure 3C, left panels, R1) but was expressed
on approximately half of the CD44hi T cells (Figure 3C, right
panels, R2+R3). Infected mice doubled their percentage of
CD44hi T cells (Figure S4A) and the CD44hi T cells from infected
mice had a similar proportion of CD200+ cells (Figure 3C). This
indicates that CD200R:CD200 expression is only acquired by
antigen experienced T cells, whether these are from naı¨ve mice
exposed to environmental antigens or from infected mice.
Staining for CD200R and CD44 detected three distinct cell
populations in MesLN that varied in their intensity of staining for
CD200R (Figure 3B). The first were naive CD44lo cells, which
were CD200R– and mostly CD200– (Figure 3C, left panels, R1).
The second were CD44hi cells which expressed intermediate
CD200R levels and were also largely CD200+ (Figure 3C, right
panels, R2+R3). These cells nearly trebled in frequency among
CD44hi CD4 T cells following infection (Figure 3B, R3). The
third, which were in the CD44lo quadrant, expressed very high
CD200R levels (Figure 3B, R4) and were identified as early
apoptotic/necrotic cells (Figure S5A). The proportion of these
CD44lo CD200R+ cells did not change with infection (Figure 3B,
R4) and were excluded from subsequent analysis. Thus, with
infection an increased fraction of the total activated T cells
(CD44hi) upregulated and co-expressed CD200R and CD200
(Figure 3C and Figure S4B).
In absolute numbers, CD44hiCD200R+ and CD44hiCD200R–
cells expanded 4- and 2.4-fold respectively during infection
(Figure 3D), suggesting that CD200R+ cells significantly outgrow
other activated cells in chronic schistosomiasis. BrdU adminis-
tration in vivo showed that CD200R+ CD4 T cells in spleen and
lymph node had proliferated upon infection (Figure 3E and S6).
Egg-derived Ag drives a strong Th2 response [6] and Th2-skewed
eGFP+ CD4 T cells increased in infected 4-get mice compared to
controls. Importantly, these eGFP+ effectors expressed higher
levels of CD200 and CD200R than their eGFP– counterparts
(Figure 3F). Together these results indicate that, during chronic
helminth infection, CD200R and its ligand CD200 are
upregulated and co-expressed in chronically activated CD4 T
cells.
CD200R Expressing T Cells Lose Multifunctional Potential
during Chronic Infection
We sought to investigate whether multifunctional cytokine
secretion had been lost in CD200R+ effectors generated during
infection, by concomitant analysis of CD200R and cytokine
expression. In both uninfected and S. mansoni infected mice a
proportion of CD4 T cells produced TNFa but these cells were
primarily CD200R– and decreased upon infection (Figure 4A and
S8A). In contrast, IL-4+ cells from infected mice were almost
exclusively CD200R+ (Figure 4A). Thus chronic infection with S.
mansoni led to differentiation of Th2 effectors with decreased
multifunctional potential, which were IL-4+, CD200R+.
CD200R expression was previously reported in Th2, but not
Th1 subsets [15], and yet we found that Th1 cells also acquired
CD200R expression in vitro (Figures 1 and 2). Infection with
Salmonella enterica is controlled by CD4 T cells making a
predominantly Th1 response which persists for several weeks
[32]. We investigated whether this chronic Th1 stimulation also
led to upregulation of CD200R on IFNc+ Th1 effectors in vivo, and
found this was the case (Figure 4B). As before (Figure 2 and 4A),
CD4 TNFa producing cells from uninfected or S. enterica infected
mice were mainly CD200R– and decreased during infection
(Figure S8B). On the other hand, infected animals had IFNc+
CD4 cells, some of which upregulated CD200R. Interestingly, and
unlike IL-4+ effector cells, ,50% IFNc+ cells remained CD200R–.
Together these data suggest that the expression of CD200R on
CD4 T cells relates to persistent Ag exposure rather than reflecting
a particular helper subset.
The Intensity of Chronic Human Schistosomiasis
Correlates with CD200R Expression in Effector T Cells
Distinct CD200R isoforms with poorly defined roles have been
identified in humans and mice, introducing the possibility that
differences in the CD200R:CD200 axis might exist between
species. CD200R mRNA expression was reported in human Th2
clones in vitro [15] and human memory T cell subsets differentially
expressed CD200R, although the reasons for such differences
remain unknown [14]. We investigated CD200R expression in
PBMC from individuals endemically exposed to Schistosoma
haematobium, the cause of urinary schistosomiasis. In agreement
with a previous study using healthy subjects [14], CD200R
expression was limited to memory/activated CD45RO+ or
CD45RA– CD4 T cells (Figure S9A). We analyzed cytokine
expression alongside CD200R expression in activated CD4 cells
from infected individuals. IL-4+ CD4 T cells were almost
exclusively CD200R+ (Figure 5A). Comparison of the MFIs
showed that IL-4+ cells had the highest expression of CD200R
(Figure 5A, bar graph). Interestingly, IFNc+ T cells from the same
individuals expressed significantly lower levels of CD200R
(Figure 5B, R3) with an MFI close to that of the CD200R–
population (Figure 5B, R1). Some cells were CD200R+ (Figure 5A
and B, R2) but produced neither IL-4 nor IFNc suggesting they
might be Th2-lineage cells refractory to restimulation in vitro. We
looked for expression of the signature Th2 transcription factor,
GATA-3, and found that the proportions of GATA-3+ cells within
the CD200R+ cells were higher than proportions of IL-4+ cells,
Figure 2. Progressive acquisition of CD200R correlates with effector cytokine secretion. Peripheral LN cells from BALB/c mice and 4-get
mice were analysed ex vivo (Naive) or after culture for 7d in transient TCR or chronic TCR stimulation conditions, as indicated, using polarising culture
conditions to promote Th2 (A) or Th1 (B) cytokine differentiation. Intracellular cytokine staining with CD200R expression is shown for TNFa, IL-2, IL-4
and IFNc. Intracellular staining with anti-GFP was used to enhance eGFP signal in 4-get cells (control stainings for anti-GFP are shown in Figure S5B &
C). Contour plots show percentage of cytokine+ gated CD4 cells; gates were based on unstimulated controls (Figure S3A and S3B). Data are
representative of 5 independent experiments. Pairwise comparison of multifunctional cytokine loss from replicate cultures is shown in Figure S3D-F.
doi:10.1371/journal.pone.0035466.g002
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Figure 3. Chronic infection induces CD200 and CD200R expression in CD4 T cells. C57BL/6 (A–E) and 4-get (F) mice were infected with
S. mansoni; MesLN (A–D, F) and spleen (E) were analyzed. A. Representative contour plot of CD44 with CD200, and B. CD44 with CD200R is shown for
gated CD4 T cells. Upon infection (8 wk), CD44hiCD200+CD4 cells (panel A, R3) increased from 7.7162.66% (n = 14) to 15.263.72% (n = 17, p,0.0001);
CD44hiCD200R+CD4 cells (panel B, R3) increased from 4.3661.69% (n = 14) to 15.364.67% (n = 17, p,0.0001). Data were pooled from 4 independent
experiments. C. Dot plots show CD200 and CD200R co-expression in CD44lo and CD44hi CD4 cells from uninfected and infected mice. D. Graph shows
CD200R:CD200 Upregulation in CD4 T Cells
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confirming that there are more Th2 lineage cells within CD200R+
CD4 T cells than indicated by IL-4+ cells (Figure 5C). Examina-
tion of multiple individuals (n = 29) showed significant linear
correlation between IL-4+ CD4 effectors and CD200R expression
by CD4 cells (Figure 5D).
Finally, since CD200R expression in mouse depended on
chronic Ag exposure, we investigated the association between
CD200Rhi CD4 T cells and infection intensity, and thus Ag load,
in a cohort (n = 29, 6–16 years) of young individuals which
included a number of healthy controls (n = 8). At the time of blood
sampling, individual infection burden was measured as urinary
schistosomal egg counts (average 21.5eggs/10ml). Potentially
confounding effects of sex and age on the analysis notwithstanding,
there was a significant correlation between infection intensity and
the proportions of CD200Rhi CD4 T cells in blood (Figure 5E).
These results indicate that S. haematobium infection intensity
influences CD200R expression in human CD4 T cells and
suggests that CD200R expression has potential as a biomarker for
parasite load.
Discussion
Expression of CD200R and CD200 by T cells has been reported
previously [14,15] but has not been correlatedwith antigen exposure
in vivo. We showed that the inhibitory receptor:ligand pair of
molecules, CD200R:CD200, was upregulated on CD4 T cells
during persistent infection. Receptor and ligand were co-expressed
on individual cells and prolonged expression of CD200R, in
particular, required sustained Ag stimulation. A fraction of the
activated, CD44hi T cells generated in chronic helminth infection
upregulated CD200R and these cells were specifically increased in
expression of IL-4/eGFP. Indeed, acquisition of CD200R paral-
leled loss of multifunctional potential together with differentiation to
effector cytokine secretion. Importantly, infection intensity positive-
ly correlated with CD200R expression by CD4T cells in individuals
endemically exposed to schistosomal Ag. These data indicate that
CD200R is a novel marker that may be used to monitor immune
responses to helminths in bothmouse andman, with implications for
evaluating immunopathology and for assessing the success of
immunotherapies for these debilitating diseases.
CD200 has a short intra-cytoplasmic tail devoid of known
signalling motifs hence it is unlikely to signal [12], mainly acting as
ligand for CD200R. However, co-expression of both receptor and
ligand on T cells introduces the possibility that these cells might
negatively regulate each other, since CD200 on T cells could bind
CD200R either in cis or trans, potentially inducing an immunoreg-
ulatory signal in CD200R+ T cells and/or myeloid-origin targets.
Further studies are required to validate these hyphotheses.
Interestingly CD200–/– mice suffer severe T cell mediated immune
pathology upon viral infection [19], implying that physiological
expression of CD200 exerts immunoregulatory control over
peripheral immune responses. Treatment with CD200 agonistic
fusion proteins ameliorated lethal immune reactions during
influenza infection, suggesting that the immunoregulatory balance
of CD200 is relevant in pathological conditions [19]. CD200
expression is relatively diffuse in epithelial and smooth muscle cells
and it is pertinent that CD200 expression is limited to certain cell
types in lymphoid tissues. We show that expression of CD200 in
activated T cells in lymphoid tissues changes substantially with
chronic infection, thus increasing the potential immunosuppressive
milieu via CD200R:CD200 interactions.
What is the biological relevance of CD200R:CD200 expression
in effector/memory T cells generated in chronic infection? The
immunoregulatory signals downstream of CD200R engagement
have been characterized in myeloid cells [13,33] but whether the
same signaling cascades are activated in T cells and potentially
integrate with TCR signals to shape lymphocyte fate remain
unknown. At the time of clonal expansion, CD200R might
influence T cell differentiation and, thereafter, exhaustion. In
support of this idea we found that multifunctional T cells which
secrete non-polarizing cytokines (i.e. TNFa and IL-2) expressed
lower amounts of CD200R while fully polarised effector T cells
acquired CD200R. Following helminth infection activated
CD200R+ CD4 T cells accumulated substantially and contained
IL-4 secreting effector cells. In human samples, higher CD200R
expression correlated positively with IL-4 secretion and GATA-3
expression. Interestingly, whereas all eGFP+ CD4 T cells during
schistosomiasis preserved CD200R, only a proportion secreted IL-
4 indicating that not all Th2-primed cells acquired/retained
effector function. A similar situation was observed in humans,
where CD200R+GATA-3+ cells outnumbered CD200R+IL-4+
cells (Figure 5C). Thus, we suggest that a substantial fraction of
CD200R+ CD4 T cells might become hyporesponsive as a
consequence of chronic Ag exposure in mice and humans. Indeed,
we found that CD200R warrants further investigation as a
biomarker for S. haematobium infection intensity as it was
considerably better than that seen with other biomarkers, such
as parasite-specific IL-4 secretion [34] or systemic levels of IL-4
[35], which are more dependent on the functional activation of
effectors, and more likely to be impaired in chronic infections.
CD200R expression was previously correlated to Th2-subset
differentiation [15]. However, our data suggested that
CD200R:CD200 expression was not limited to Th2 conditions,
but rather may be more generally involved in chronic Ag exposure.
CD200R was upregulated in both Th1 and Th2 cells in vitro and
during S. mansoni and S. enterica infections. Similarly in S. haematobium
infected humans, we found that CD200R expression was signifi-
cantly increased in Th2-prone cells. However IFNc+ cells from the
same individuals also showed low but significant expression of
CD200R. Although we show that CD200R is not limited to Th2 T
cells, the regulation of CD200 and CD200R between Th1 and Th2
cells may differ depending on the TCR signal strength necessary for
their differentiation. CD200:CD200R expression has been linked
previously to the control of autoimmunity [18] and to immune
evasion by tumour cells [21]. We show here that they are also
relevant in CD4 T cell response to persistent infections. These data
raise the possibility that these molecules will be valuable markers of
infection intensity in chronic helminth infections and they may have
potential as therapeutic targets.
absolute numbers of CD200R+ (panel B, R3) and CD200R– (panel B, R2) CD44hiCD4 cells from 4 independent experiments. Upon infection
CD44hiCD200R+ cells increased from (2.760.6)6105 (n = 14) to (10.863.2)6105 (n = 17, ***p = 3.03610–10), while CD44hi CD200R– cells increased from
(7.963.3)6105 to (18.6611.9)6105 (**p = 0.003). E. Contour plots show CD200R expression in proliferating (BrdU+) cells, in gated CD4 cells for spleen
of uninfected and infected mice. Upon infection BrdU+CD200R+ CD4 T cells increased from 4.560.69 (n = 4) to 46.6617 (n = 10) p,0.0005. Specificity
controls for BrdU staining are shown in Figure S7A & B. F. Contour plots (left) show CD200 and eGFP expression; CD200+GFP+CD4 cells increased from
0.6460.12% to 13.767.24% after infection (p = 0.01, n = 4). Histogram overlays (right) show CD200 and CD200R levels in gated GFP+ (green line) and
GFP– (filled histograms) CD4 cells from infected mice. Control stainings for intracellular GFP staining are shown in Fig S5B & C. ** = p,0.0001,
* = p,0.001. Results are representative of at least 4 (A–D) and 3 (E-F) independent experiments (n = 3 mice/group).
doi:10.1371/journal.pone.0035466.g003
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Figure 4. Effector cytokine potential is acquired alongside CD200R expression in vivo. Dot plots show cytokine+ gated CD4 cells ex vivo (-
P/I) and after recall with pdbU + Ionomycin (+P/I, 5h); gates are based on unstimulated controls (-P/I). A. Infection with S. mansoni (8wk) increased
CD200R+ IL-4+ CD4 cells in MesLN from 0.01760.019% to 3.3961.36% and 8364.14% of IL-4+ cells were CD200R+, while CD200R– TNFa+ CD4 cells
decreased from 47.564.66% to 30.060.99%. (n = 3, p = 0.01). B. Infection with S. enterica increased IFNc+ CD4 cells in spleen from 1.960.65% to
31.164.4% and 49.569.86% of IFNc+ cells were CD200R+, while CD200R– TNFa+ CD4 cells decreased from 19.662.31% to 15.161.56%. (n = 5,
p = 0.01). Results are representative of at least 3 (A, n = 3 mice/group) and 2 (B, n = 5 mice/group) independent experiments.
doi:10.1371/journal.pone.0035466.g004
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Figure 5. CD200R correlates with infection intensity in human schistosomiasis. Expression of CD200R and IL-4 (A) or IFNc (B) in gated CD4
T cells from blood after recall with PMA + Ionomycin. Isotype control stainings are shown in Figure S9. Charts show mean (6s.e.) of CD200R MFI in R1-
3. C. CD200R-, CD200Rlo and CD200Rhi abTCR+CD4 cells were analysed for IL-4 and GATA-3 expression. One representative sample is shown in left
histograms. Mean percentage (6s.e.) of cells in each population are shown in the bar graph. * = p,0.05, ** = p,0.01 (n = 8, ANOVA A–C). D.
Correlation between the percentages of IL-4+ and CD200R+ CD4 T cells, respectively determined by intracellular and surface stain. E. Correlation
between the proportions of CD200RhiCD4 T cells and infection intensity determined as urine egg counts (n = 29, D-E). Percentages of CD200RhiCD4
T cells and IL-4+CD4 T cells were arcsine square root transformed to allow the use of parametric tests. Infection intensity was Log10(x+1) transformed.
To allow for potential confounding effects of sex (categorical variable) and age (continuous variable) transformed data were assessed by ANOVA.
Resulting residuals were used to analyse the correlation between both CD200RhiCD4 T cells and IL-4+CD4 T cells or between CD200RhiCD4 T cells and
infection intensity of which the r-correlation coefficients and p-values are indicated.
doi:10.1371/journal.pone.0035466.g005
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Materials and Methods
Mice and Infections
C57BL/6, BALB/c, DO11.10 and 4-get (IL-4-eGFP) mice were
bred at the University of Edinburgh (UK). DO11.10 mice are
transgenic for the OVA323–339 peptide-specific TCR restricted by
I-Ad on a BALB/c genetic background [36], while 4-get mice have
an IRES-eGFP reporter knocked into the IL-4 locus and report
the presence of IL-4 mRNA and protein [29]. Maintenance and
experimentation of animals were carried out under guidelines
overseen by the University of Edinburgh Biological Services
Ethical Review Panel Application PL26-07 and the UK Home
Office.
Biomphalaria glabrata snails infected with S. mansoni were obtained
from Dr. Fred Lewis (NIAID Schistosomiasis Resource Center at
Biomedical Research Institute, Rockville, MD). Mice were
infected percutaneously (80-180 cercariae) as described [30]. Mice
received BrdU (i.p. and orally) 4d before analysis and incorpora-
tion was determined as described [37,38].
The aroA attenuated strain of S. enterica serovar Typhimurium,
SL3261, was used in infections [39], as previously described (106
CFU/mouse, i.v.) [40]. In spleen, bacterial loads were typically 2–
56105 CFU/g.
Study Population and Human Patients
Blood samples were obtained from residents in Mashonaland
East Province of Zimbabwe (31o91’E; 17o63’S), a Schistosoma
haematobium endemic region. Permission for study execution in the
area was obtained from the Provincial Medical Director while
institutional approval was obtained from the University of
Zimbabwe. Ethical approval for the study was obtained from the
Medical Research Council of Zimbabwe. Participants are enrolled
in an ongoing immuno-epidemiology study of human schistosomi-
asis, never underwent anti-helminthic treatment prior to this study
and received anti-helminth drug, praziquantel (40 mg/kg) at the
end of the study. Study aims and procedures were explained to
participants and their parents/guardians in the local language prior
to enrollment. Written consent was obtained from all participants or
their parents/guardians in case of children. Participants were free to
leave the study at any time during the study.
Mouse T Cell Primary Cultures
Peripheral lymph node cells were pooled from axillary, inguinal,
brachial, and cervical lymph nodes (excluding mesenteric
(mes)LN). Where explicitly stated in the figure legends mesLN
were collected. After lymphoid organ disaggregation, cells were
washed and resuspended in complete media (RPMI-1640,
5%FCS, 2 mM L-gln, 100 U/ml penicillin/streptomycin, and
2.5610–5 M 2b-ME (Invitrogen)). Anti-CD3 (Clone 145-2C11,
BD) at 0-1 mg/ml and anti-CD28 (Clone 37.51, BD) at 2 mg/ml
mAb were coated on plates (1h, 37uC, in PBS) and washed twice.
In transient TCR stimulations, cells were moved from Ab-coated
to fresh wells on d2. aAPC were described previously [25].
aAPC:CD4 cell ratios in culture were 2.5:1. Polarising culture
conditions were: Th1: IL-12 (Peprotech, 5 ng/ml) and anti–IL-
4 mAb (11B11, BD); Th2: IL-4 (Peprotech, 5 ng/ml) and anti-IL-
12 mAb (C17.8, BD) and non-polarising cultures: IL-7 (Peprotech,
50 ng/ml). Blocking mAb (2.5 g/ml) were added on d0 and d3.
Flow Cytometry
Mouse cells were incubated with anti-FcR blocking mAb
(Biolegend) for 10 min, at RT and stained (15 min, 4uC) with
PE-TexasRed- or PerCP-labeled anti-CD4 (BD) and PE-labeled
anti-CD44 (IM7, eBioscience), APC-labeled anti-CD200
(eBioscience), FITC-labeled anti-CD200R (Serotec) mAb. Human
PBMC were isolated (LymphoprepTM) and cryo-preserved.
Following thawing, cells were resuspended in complete media,
washed twice, counted (Trypan Blue) and stained with Alexa-488-
labeled anti-CD4 (OKT-4), PE-labeled anti-CD200R (Ox108),
v500-labeled anti-CD8 (from eBioscience) with Pacific blue-
labeled anti-abTCR (IP26, Biolegend). Isotype control staining
for CD200 and CD200R Abs are shown in Figure S7 (mouse) and
Figure S9 (human).
Intracellular cytokine staining: 56105 T cells were incubated
with PerCP-labeled anti-CD4 and FITC-labeled anti-CD200R
mAb and stimulated with PdbU (70 ng/ml), Ionomycin (1 mg/ml)
and BrefeldinA (5 mg/ml) for 5 h at 37uC. After fixation in 2%
isotonic formaldehyde and permeabilization in buffer containing
PBS 2%FCS, 0.2%NaN3, 0.5% saponin, 2% rat serum, cells were
stained with anti–IL-2, anti–IL-4 (both BD), anti–IFNc, anti–
TNFa (both eBioscience) and anti-GFP mAb (Invitrogen) for
30min at RT. Cells were washed twice in permeabilization buffer.
Human PBMC were incubated for 4 h at 37uC with PMA (10 ng/
ml), Ionomycin (1 mM) and GolgiStopTM, washed, and stained for
surface markers as described above, then permeabilized and
stained with PE-Cy7-labeled anti-IL-4 and anti-IFNc mAb
(eBioscience). Cells were washed in staining buffer before
acquisition on FACSCaliburTM or LSR II cytometers (BD). Data
were analyzed in FlowJo software (TreeStar, Ashland, USA).
Statistical Analyses
Unpaired two-tailed t-test was used in mouse studies, unless
indicated in the Figure legend that paired t-test was used. SPSSv14
software was used for analysis of human data [41]. In the human
studies, percentages of CD200RhiCD4 T cells and IL-4+CD4
T cells were arcsine square root transformed to allow the use of
parametric tests. Infection intensity was Log10(x+1) transformed.
To allow for potential confounding effects of sex (categorical
variable) and age (continuous variable) transformed data were
assessed by ANOVA. Resulting residuals were used to analyse the
correlation between both CD200RhiCD4 T cells and IL-4+CD4
T cells or between CD200RhiCD4 T cells and infection intensity
of which the r-correlation coefficients and p-values are indicated.
Supporting Information
Figure S1 T cells co-express CD200 and CD200R
following TCR stimulation. A. Naı¨ve C57BL/6 peripheral
LN cells were cultured with a titration of anti-CD3 + anti-CD28
(2 mg/ml) (white bars) or only with recombinant mouse IL-7
(10 ng/ml, black bar) for 3d. Bar graphs show average6SEM
Mean Fluorescence Intensity (MFI) expression of CD200 (left) and
CD200R (middle) in CD4 T cells and percentage of CD200+
CD200R+ CD4 T cells, in technical replicates for each plotted
condition. Upon TCR stimulation, CD4 T cells significantly
increased levels of CD200 and CD200R expression and co-express
CD200:CD200R (***p= 0.0005, NS=not significant), while IL-7-
treated cells did not significantly differ from unstimulated controls.
An independent biological replicate of Fig. 1A is presented. B. At
an early time point (d3), CD4 T cells showed similar activation
under all stimulation conditions. Naı¨ve peripheral LN cells were
transiently or chronically stimulated (as in Fig 1A) with anti-CD3
(1 mg/ml) + anti-CD28 (2 mg/ml), as indicated, in Th1 (top row),
Th2 (middle row) or non-polarising (IL-7, bottom row) conditions.
Histograms (unfilled) show expression of activation markers CD25
(left columns) and CD44 (right columns) compared to naı¨ve
controls (filled histograms) in CD4 gated T cells.
(TIF)
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Figure S2 CD4 T cells co-express CD200 and CD200R
upon chronic activation. A. Co-expression of CD200R and
CD200 is shown from the experiment in Fig. 1C. Naı¨ve LN cells
were transiently (top rows) or chronically (bottom rows) stimulated
with anti-CD3 (1 mg/ml) + anti-CD28 (2 mg/ml) in Th1, Th2, or
non-polarising (IL-7) conditions. Contour plots show co-expression
of CD200 and CD200R in CD4 gated T cells at d3 (top panels)
and d7 (bottom panels) compared to the levels found in naı¨ve CD4
T cells (left end column). Chronic TCR stimulation favoured co-
expression of CD200 and CD200R and, by d7, the percentage of
CD200+ CD200R+ CD4 T cells was significantly higher in chronic
rather than transient stimulations, compared using a paired 2-
tailed t-test (p,0.05). Additionally, CD200:CD200R co-express-
ing CD4 cells significantly increased from d3 to d7 in chronically
stimulated conditions (paired 2-tailed t-test, p,0.05). B. Co-
expression of CD200:CD200R occured primarily on activated
CD25+CD44+ CD4 T cells. As an example, T cells cultured with
chronic TCR stimulation for 7d under Th1 conditions are shown
for expression of activation markers, CD44 and CD25. Th1
activated cells (left overlay, black dots) upregulated both CD44
and CD25 compared to naı¨ve controls (left overlay, blue dots).
74% of CD44+ CD25+ CD4 T cells co-expressed
CD200:CD200R (red dots in right overlay). Equivalent profiles
were obtained in any other chronic condition.
(TIF)
Figure S3 Specificity of intracellular cytokine staining
and significant upregulation of CD200R expression
following transient versus chronic TCR stimulation. A-
B. Control staining (not stimulated with PdbU + iono) is shown for
the intracellular cytokine stains presented in Fig. 2. In the absence
of restimulation very little background cytokine staining was
observed. C. Bar graph shows the percentage of CD200R+ CD4+
T cells in transient (n = 11, grey) and chronic (n = 11, black) TCR
stimulations (Mean6SEM) compared with naı¨ve (n = 4, white)
controls, evaluated across all polarising conditions in 4 biological
repeats of experiments shown in Fig. 1C and 2. CD200R up-
regulation compared to naı¨ve controls is shown following transient
stimulation (4.8360.83 to 21.963.4, *p = 0.01) and chronic
stimulation (4.8360.83 to 55.066.84, **p = 0.001) and between
transient and chronic stimulation conditions (*p = 0.01, unpaired
t-test). D. Shows 4 pooled biological repeats (n = 11) comparing
the percentage of CD200R+ CD4 T cells under chronic and
transient TCR stimulation linked by experiment under all
polarising condition (*p= 0.01, n = 11, paired t-test). E. The
percentage of CD200Rneg IL-2+ (n = 11) and F. CD200Rneg
TNFa+ (n = 8) in transient compared to chronic TCR stimulations
linked by experiment from 4 pooled biological repeats is shown.
Upon chronic stimulation, CD200Rneg IL-2+ (E) and TNFa+ (F)
CD4 T cells decreased significantly (***p= 0.0001 and
**p= 0.001).
(TIF)
Figure S4 Chronic infection causes an increase in
activated CD4 T cells that co-express CD200:CD200R.
C57Bl/6 mice were infected with S. mansoni and MesLN were
analyzed. A. Graph shows the percentage (mean6SD) of
activated/memory-phenotype, CD44hi CD4 T cells in infected
mice (n = 17) compared to naı¨ve, uninfected controls (n = 14)
8 weeks after infection. CD44hiCD4 cells increased from
12.662.34% (n= 14) to 31.963.93% (n= 17, ***p = 4.86610–16,
2-tailed, unpaired t-test). B. The percentage (mean6SD) of
CD200+CD200R+CD4 cells in infected mice (n = 17) compared
to naı¨ve un-infected controls (n = 14) is shown. Upon infection,
CD4 cells co-expressing CD200 and CD200R increased signifi-
cantly from 7.8263.52% (n= 14) to 19.367.72% (n= 17,
***p = 1.70610–5, 2-tails, unpaired t-test). Data are pooled from
the same 4 biological repeats shown in Fig. 3.
(TIF)
Figure S5 Dying cells express very high levels of
CD200R. A. Contour plots show expression of CD44 and
CD200R in total compared to viable CD4 T cells, based on
forward and side scatter discrimination. Total CD4 T cells (left)
show two populations of CD200R staining (R1 and R2), which
disappear once dead cells are excluded in the viable gate (right).
One example out of with 17 mice infected with S. mansoni from
4 independent experiments is shown. Specificity of intracellular
IL-4 and GFP staining. B-C. An independent biological repeat of
Fig. 3F shows the specificity of GFP detection in infected 4-get
mice. B. No signal is dected in the GFP channel in intact cells from
either S. mansoni infected wild-type C57BL/6 mice or naı¨ve
uninfected 4-get control mice. Upon infection, GFP+ CD4 T cells
increased and homogenously upregulated CD200 expression in
infected 4-get, but not C57BL/6 mice. C. Specificity of GFP signal
is shown with indirect GFP detection using anti-GFP mAb in
intracellular cytokine staining together with anti-IL-4, as in Fig. 2.
In unstimulated controls (bottom panels, -P/I), GFP+ CD4 cells
were only detected in infected 4-get mice and did not actively
secrete IL-4. Upon 5h-restimulation in the presence of PdbU and
Ionomycin (top panels, +P/I), IL-4+ CD4 cells detected in infected
mice were GFP+ in 4-get, but not control C57BL/6 mice.
(TIF)
Figure S6 CD4 T cells in S. mansoni infected animals
proliferate and accumulate while upregulating CD200R.
C57BL/6 mice were infected with S. mansoni and received BrdU
(i.p. and orally) 4 days before analysis. BrdU incorporation was
measured in the MesLN (A–D) and the spleen (D) as described in
Materials and Methods. A-B. Contour plots show specificity of
BrdU staining (A. anti-BrdU mAb, clone 3D4, B. isotype control)
with expression of CD44 (left panels) or CD200R (right panels) in
uninfected (top row) and infected (bottom row) mice. C. Graphs
show the percentage of activated/memory-phenotype (mean6-
SEM) CD44hi (left) and CD200R+ (right) CD4 T cells incorpo-
rating BrdU compared to isotype control in infected (n= 4) and
uninfected, naı¨ve, mice (n = 4). Upon infection (8 wk),
CD44hiBrdU+ and CD200R+BrdU+ CD4 cells increased signifi-
cantly from 3.5660.14% (n= 4) to 8.3161.06% (n= 4, **p = 0.01,
2-tails, unpaired t-test) and from 1.5560.0.06% (n= 4) to
5.4460.6% (n= 4, ***p= 0.001, 2-tails, unpaired t-test), respec-
tively. D. Graphs show absolute numbers (6SD) of
CD200R+BrdU+ CD4 cells in mesenteric LN (left) and spleen
(right), after background subtraction based on isotype controls (B-
C). Upon infection, CD200R+BrdU+ CD4 cells accumulated
significantly in the mesLN between naı¨ve and infected mice, from
(5.6160.74)6104 (n = 4) to (35.4614.5)6104 (n = 4, *p= 0.05)
and, in the spleen, from (35.9610.9)6104 (n = 4) to
(3006192)6104 (n = 4, *p= 0.05). Independent biological repeat
of Fig. 3E.
(TIF)
Figure S7 Specificity of CD200 and CD200R mAb
staining. A. Dot plots show staining of FITC-labeled Rat IgG2a
isotype control (left) or anti-CD200R mAb (right) together with
expression of activation marker, CD44, in mouse CD4 T cells. B.
Dot plots show staining of APC-labeled Rat IgG2a isotype control
(left) or anti-CD200 mAb (right) together with expression of
activation marker, CD44, in mouse CD4 T cells. In the upper left
quadrants, the average6SD frequency of CD44hi CD200R+ (A)
or CD200+ (B) CD4 T cells is indicated (n = 3 biological
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replicates), showing increased detection of CD200R and CD200 in
memory-phenotype cells over the relative isotype controls.
(TIF)
Figure S8 CD200R expression in vivo correlates in-
versely with TNFa and IL-2 cytokine production. Bar
graphs show (mean6SEM) detection of A. TNFa and B. IL-2
cytokine+ CD200Rneg CD4 cells ex vivo after recall with PdbU +
Ionomycin (+P/I, 5h) as shown in Fig.4. A. Infection with S.
mansoni (8wk, left) or S. enterica (2wk, right) decreased
CD200RnegTNFa+ CD4 cells in mesLN from 35.664.4% to
18.163.1% (*p= 0.01, n= 10/group, data pooled from 3
independent biological repeats) in S. mansoni infection and in
spleen in S. enterica infection from 32.665.2% to 12.361.4%
(**p = 0.001, n= 10/group, data pooled from 2 independent
biological repeats). B. In agreement with the loss of TNFa,
infection also decreased CD200RnegIL-2+ CD4 cells in LN (S.
mansoni at 8wks) from 34.261.67% to 21.061.37% (**p = 0.001,
n = 4/group) and in spleen (S. enterica at 2wks) from 23.560.95%
to 0.8260.0.16% (***p= 0.0001, n = 5/group).
(TIF)
Figure S9 Expression of CD200R in human CD45RA–
CD4+ abTCR+ cells and isotype controls for intracellular
stains. A. Dot plots show expression of CD45RA and CD200R
mAb (left), compared to isotype control stains (mouse IgG1, right),
in gated abTCR+ CD4+ lymphocytes from human PBMC. As
previously found in Rijkers et al. (14), memory-phenotype
(CD45RA–) CD4 T cells specifically up-regulated CD200R
expression. B. Dot plot shows the isotype control stains for IL-4/
IFNc (y-axis) and CD200R (x-axis) mAbs used for the intracellular
staining of human CD4+ T cells in Fig. 5A-B. C. Dot plots show
intracellular stain of GATA-3 (right panel) versus an isotype
control stain (left panel) after gating on CD4+ T cells, as used in
Fig. 5C.
(TIF)
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